Okada Ken
Research Center for Advanced Agrotechnology and Biotechnology, Toyohashi University of Technology, 1-1 Hibarigaoka, Tempaku-cho, Toyohashi, Aichi 441-8580, Japan.
FEBS Lett. 2009 Jan 22;583(2):313-9. doi: 10.1016/j.febslet.2008.12.015. Epub 2008 Dec 13.
The metabolic pathways in apicoplasts of human malaria parasites are promising drug targets. The apicomplexan parasites exhibit delayed cell death when their apicoplast is impaired, but the metabolic pathways within apicoplasts are poorly understood. A nuclear-encoded heme oxygenase (HO)-like protein with an apicoplast-targeted bipartite transit peptide was identified in the Plasmodiumfalciparum genome. Purified mature recombinant PfHO protein converted heme into bilirubin IXalpha as confirmed by high-performance liquid chromatography. In addition, PfHO required an iron chelator such as deferoxamine for complete activity. These observations lead to the conclusion that a novel enzymatic heme degradation system is present in human malaria parasites.
人类疟原虫顶质体中的代谢途径是很有前景的药物靶点。当顶复门寄生虫的顶质体受损时,它们会出现细胞死亡延迟的情况,但顶质体内的代谢途径却知之甚少。在恶性疟原虫基因组中鉴定出一种具有靶向顶质体的双功能转运肽的核编码类血红素加氧酶(HO)样蛋白。通过高效液相色谱法证实,纯化的成熟重组PfHO蛋白可将血红素转化为胆红素IXα。此外,PfHO需要铁螯合剂(如去铁胺)才能完全发挥活性。这些观察结果得出结论,人类疟原虫中存在一种新型的酶促血红素降解系统。